Prescribing of Tirzepatide/Mounjaro® on the NHS (updated)

You may have heard in the news that NHS England and NICE have approved Tirzepatide, which is also known by its brand name Mounjaro® for use in primary care starting from 23rd June 2025.

This is a significant development in the management of obesity and type 2 diabetes. However, the medicine is only approved for a very small number of people who meet the strict criteria during the first two years of rollout. This is a decision made by NHS England to ensure a safe and gradual introduction of the medication into the healthcare system.

For patients in Hertfordshire and West Essex, Tirzepatide for weight loss will be available through a new service that is in the process of being set up. This service will provide access to Tirzepatide injections as part of a 9-month healthy lifestyle programme.

Fernville will not be able to prescribe Tirzepatide/Mounjaro® directly. You can only get it through the new service.